Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous Teicoplanin for Osteoarticular Infections
NCT01815541Phase 2Completed
- Sponsor
- CHU Amiens-Picardie
- Start
- Mar 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of teicoplanin in Osteoarticular infection (OAI), sponsored by CHU Amiens-Picardie. Started Mar 2013; status: completed.
02
Drugs
teicoplanin
03
Conditions
Osteoarticular infection (OAI)
Beyond the preview
Go deeper on NCT01815541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01815541.